Pratik Bhagunde

Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model

Jin Wu, Fred Racine, Michael K. Wismer et al. · Antimicrobial Agents and Chemotherapy · 2018 · 61 citations · Full text

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

Pratik Bhagunde, Kai-Tai Chang, Elizabeth B. Hirsch et al. · Antimicrobial Agents and Chemotherapy · 2012 · 59 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +22

Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

Pratik Bhagunde, Parul Patel, Mallika Lala et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 59 citations · Full text

Population Pharmacokinetic Analysis, Pharmacotherapy, Nephrology +22

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder et al. · Antimicrobial Agents and Chemotherapy · 2018 · 55 citations · Full text

A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam

Pratik Bhagunde, Zufei Zhang, Fred Racine et al. · International Journal of Infectious Diseases · 2019 · 47 citations · Full text

Translational Pharmacokinetic/pharmacodynamic Model, Antimicrobial Susceptibility, Health Sciences +13